Retatrutide Syringe & Needle Selection: 1mL Insulin Syringe + 29-31G Guide for UAE Researchers (2026)

Published 24 June 2026 · REVIVE Peptides Research Desk · 11 min read
TL;DR. For retatrutide research dosing in the UAE, use a 1mL (100 IU) U-100 insulin syringe with a fixed 29-31G x 8mm needle. From a 10 mg vial + 2 mL bacteriostatic water (5 mg/mL), a 4 mg dose draws to 80 IU; from a 5 mg vial + 1 mL BAC water (5 mg/mL) a 1 mg dose draws to 20 IU. Stock the syringes at Aster, Life, or BinSina pharmacies (AED 3-6 each). Retatrutide 5/10 mg vials ship same-day across Dubai, next-day to Abu Dhabi and Sharjah from REVIVE.

Why Syringe Selection Matters More Than Researchers Realise

Retatrutide is a triple agonist of GLP-1, GIP, and glucagon receptors (Coskun 2022, Cell Metab). Its therapeutic research window is wide — Jastreboff 2023 (NEJM) tested doses from 0.5 mg up to 12 mg weekly — which means draw volumes can swing from 5 IU all the way to 240 IU on a U-100 scale. Using the wrong syringe (1 mL tuberculin without IU markings, or 3 mL Luer-lock with a 21G drawing needle) introduces two preventable failure modes:

  1. Dose error. Trying to read 0.10 mL on a 3 mL barrel is guesswork. A 100 IU scale syringe lets you see every 2 IU clearly.
  2. Tissue trauma at SC sites. A 21G or 23G needle is for IM injection or vial-drawing — not for the subcutaneous tissue retatrutide actually targets. Fine-gauge insulin needles (29-31G) cause minimal capillary disruption and almost no visible bruising.

For researchers ordering from Buy Retatrutide UAE 24h delivery, getting syringe selection right on day one prevents the entire titration schedule from compounding errors. This guide pins down exactly which barrel, exactly which needle, and exactly which pharmacy chain in the UAE stocks them.

The Standard: U-100 Insulin Syringe + 29-31G x 8mm Fixed Needle

"U-100" means the syringe is calibrated for a solution containing 100 units per mL — the universal insulin standard. For retatrutide research this is convenient because:

The conversion is purely volumetric — IU here is just a synonym for "1/100th of a mL" since retatrutide is not insulin. The math holds whether you reconstitute at 5 mg/mL or 10 mg/mL (see retatrutide reconstitution math).

Brands stocked in UAE pharmacies

BrandNeedleCapacityUAE retail (per syringe)
BD Micro-Fine Plus29G or 30G x 8mm fixed1 mL / 100 IUAED 4-6
BD Micro-Fine Demi30G x 6mm fixed0.5 mL / 50 IUAED 4-5
Terumo Myjector29G or 30G x 8mm fixed1 mL / 100 IUAED 3-5
Nipro JustFit30G or 31G x 8mm fixed1 mL / 100 IUAED 3-4
Omnican (B. Braun)30G x 8mm fixed1 mL / 100 IUAED 5-6

Avoid removable-needle insulin syringes for retatrutide. The fixed-needle versions have a sub-microlitre dead space — meaning no peptide is wasted in a Luer hub between draw and inject. For an expensive triple agonist, dead-space matters: a removable 30G hub can hold 0.07-0.10 mL, enough to silently lose 0.7 mg from a 5 mg/mL solution every injection.

Draw Volume Math — 5 mg and 10 mg Vials

REVIVE ships retatrutide in two strengths: 5 mg vials and 10 mg vials. The draw volume depends on (a) the vial strength and (b) how much bacteriostatic water you reconstitute with. The reference tables below cover the four most common reconstitution scenarios.

Scenario A: 5 mg vial + 1 mL BAC water = 5 mg/mL

Target doseVolume to drawIU on U-100 syringe
0.5 mg0.10 mL10 IU
1 mg0.20 mL20 IU
2 mg0.40 mL40 IU
4 mg0.80 mL80 IU
5 mg (full vial)1.00 mL100 IU

Scenario B: 10 mg vial + 2 mL BAC water = 5 mg/mL

Target doseVolume to drawIU on U-100 syringe
0.5 mg0.10 mL10 IU
1 mg0.20 mL20 IU
2 mg0.40 mL40 IU
4 mg0.80 mL80 IU
8 mg1.60 mL (split into 2 draws)2 x 80 IU
12 mg2.40 mL (split into 3 draws)3 x 80 IU

Scenario C: 10 mg vial + 1 mL BAC water = 10 mg/mL (concentrated)

Target doseVolume to drawIU on U-100 syringe
1 mg0.10 mL10 IU
2 mg0.20 mL20 IU
4 mg0.40 mL40 IU
8 mg0.80 mL80 IU
12 mg1.20 mL (split into 2 draws)2 x 60 IU

Scenario C is the preferred reconstitution for late-titration researchers (8-12 mg target) because it keeps the entire dose inside a single 1 mL barrel — no splitting required until the very top dose.

Scenario D: 5 mg vial + 2 mL BAC water = 2.5 mg/mL (dilute)

Target doseVolume to drawIU on U-100 syringe
0.25 mg0.10 mL10 IU
0.5 mg0.20 mL20 IU
1 mg0.40 mL40 IU
2 mg0.80 mL80 IU

Scenario D is for ultra-low starting doses (0.25 mg) where researchers want maximum readability on the syringe. The trade-off: only useful up to 2 mg before requiring multiple injections.

Buy Retatrutide in the UAE — 24h Delivery to Dubai, Abu Dhabi, Sharjah
REVIVE stocks retatrutide 5 mg and 10 mg vials with HPLC certificates, cold-chain dispatch, and syringe pairing recommendations. Same-day Dubai, next-day Abu Dhabi.
Order Retatrutide UAE 24h Delivery →

UAE Pharmacy Sourcing — Aster, Life, BinSina

The three dominant UAE pharmacy chains all stock 1 mL insulin syringes over-the-counter. None require a prescription for the syringe itself — they are sold for routine diabetic supply. Pricing and stock depth vary slightly:

Aster Pharmacy

Life Pharmacy

BinSina Pharmacy

For researchers running a full 24-week titration on weekly injections, a single box of 100 covers nearly two years of dosing. Stock once, store at room temperature in original packaging, and the syringes remain sterile until the foil pouch is opened.

Where to Buy Retatrutide in the UAE — 24h Delivery

The syringe is the easy half. The peptide itself is what requires a verified research-grade source with proper cold chain. REVIVE Peptides operates from Dubai with the following delivery matrix:

EmirateDelivery windowCourierCold chain
DubaiSame-day (order before 14:00)REVIVE in-house courierInsulated gel pack, 2-8°C
Abu DhabiNext-day (24h)Aramex Cool ChainInsulated gel pack, 2-8°C
SharjahSame-day or next-dayREVIVE in-house courierInsulated gel pack, 2-8°C
AjmanNext-day (24h)REVIVE in-house courierInsulated gel pack, 2-8°C
Ras Al Khaimah24-48hAramex Cool ChainPhase-change panel, 2-8°C
Fujairah24-48hAramex Cool ChainPhase-change panel, 2-8°C
Umm Al Quwain24-48hAramex Cool ChainPhase-change panel, 2-8°C

Cold chain logistics that actually matter in UAE summers

Lyophilised retatrutide is stable at room temperature for short transit windows but degrades faster as ambient temperatures climb past 30°C — and UAE summer outdoor temperatures regularly exceed 45°C. REVIVE ships every vial inside an insulated EPP container with a frozen gel pack rated for 12-24 hours of 2-8°C maintenance. Once delivered, the vial moves directly to a refrigerator (see peptide fridge storage UAE).

REVIVE Dubai stock and ordering process

  1. Stock confirmation. Retatrutide 5 mg and 10 mg vials are held in temperature-controlled storage in Dubai. Real-time stock shown on the retatrutide product page.
  2. Order cutoff. Dubai same-day requires orders before 14:00 GST. Orders after 14:00 ship next morning.
  3. Payment. Cash on delivery, bank transfer, or card. No prescription required for research-grade material.
  4. Tracking. Live courier link sent on dispatch.
  5. Companion supplies. Add bacteriostatic water 3 mL and insulin syringes at checkout — bundled cold-chain dispatch.

Browse the full UAE catalogue at REVIVE Peptides UAE.

Injection Technique With a 29-31G Insulin Needle

The fine gauge changes injection mechanics slightly compared to a thicker 25G or 23G needle. Key points:

What to Avoid — Syringes That Will Sabotage a Retatrutide Protocol

  1. Tuberculin 1 mL syringes with no IU markings. The mL-only scale is too coarse for sub-0.1 mL draws.
  2. 3 mL or 5 mL syringes with 21-25G Luer needles. Designed for IM or vial-draw work, not SC delivery.
  3. Auto-injector pens not designed for compounded peptides. Cartridge volume and concentration won't match research reconstitution.
  4. Reused single-use syringes. 29-31G needle tips burr after one use — the second injection is noticeably more traumatic and increases infection risk.
  5. Syringes stored after foil pouch opening. Sterility cannot be guaranteed once the pouch is breached.

Pairing Syringes With Bacteriostatic Water and Vial Strength

A complete retatrutide research kit from REVIVE UAE includes:

For the math of matching vial strength to BAC water volume to syringe draw, the retatrutide reconstitution math guide walks through every combination. For dose progression itself, the retatrutide titration schedule UAE covers when to step up and when to hold.

Research use only. Retatrutide and associated syringes supplied or recommended by REVIVE Peptides are labelled and sold strictly for in-vitro and research purposes — not for human consumption. Insulin syringes are widely sold OTC in the UAE for legitimate diabetic supply; their use for research peptide handling is documented here for accuracy, not as a clinical instruction.

References

  1. Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial. N Engl J Med. 2023;389(6):514–526.
  2. Coskun T, Urva S, Roell WC, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss. Cell Metab. 2022;34(9):1234–1247.
  3. Rosenstock J, Frias J, Jastreboff AM, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial. Lancet. 2023;402(10401):529–544.
  4. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384(11):989–1002.
  5. Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740–756.
  6. Müller TD, Finán B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72–130.
  7. Sanyal AJ, Bedossa P, Fraessdorf M, et al. A phase 2 randomized trial of survodutide in MASH and fibrosis. N Engl J Med. 2024;391(4):311–319.